@article{11b01e988c694f6c96f505d9d756533d,
title = "Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health",
keywords = "adrenergic beta-antagonists, blood pressure, capillary hemangioma, child, growth and development, infant, long-term adverse effects, vascular malformations, vascular tissue neoplasms",
author = "Hermans, {Mireille M} and Pasmans, {Suzanne G M A} and {de Laat}, {Peter C J} and Slieker, {Martijn G} and Mendels, {Elodie J} and {de Graaf}, Marlies and Langeveld, {Hester R} and Renske Schappin and Rietman, {Andr{\'e} B} and Breugem, {Corstiaan C} and Breur, {Johannes M P J} and {de Wildt}, {Saskia N} and Raphael, {Martine F}",
note = "Funding Information: Funding sources: This investigator-initiated study was carried out with an unrestricted grant provided by Pierre Fabre Dermatologie. ",
year = "2023",
month = jun,
doi = "10.1016/j.jdin.2023.02.001",
language = "English",
volume = "11",
pages = "137--139",
}